Risk factors and outcomes of intensive care unit-acquired infections in a Tunisian ICU

Case Reports and Clinical Practice Review

Volumn 16, Issue 8, 2010, Pages

  Kallel, Hatem ^a   Dammak, Hassen ^a   Bahloul, Mabrouk ^a   Ksibi, Hichem ^a   Chelly, Hedi ^a   Hamida, Chokri Ben ^a   Rekik, Noureddine ^a   Bouaziz, Mounir ^a  

^a HABIB BOURGUIBA HOSPITAL   (Tunisia)

Author keywords

Antibiotics; Intensive care unit; Mortality; Nosocomial infection; Prevention

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; AMOXICILLIN;

ACINETOBACTER BAUMANNII; ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BLOODSTREAM INFECTION; CENTRAL VENOUS CATHETER; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEALTH SURVEY; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INCIDENCE; INFECTION RISK; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PRESCRIPTION; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; SEPTIC SHOCK; TREATMENT OUTCOME; TUNISIA; UNIVERSITY HOSPITAL; VENTILATOR ASSOCIATED PNEUMONIA; BACTERIUM; CROSS INFECTION; INFANT; ISOLATION AND PURIFICATION; KAPLAN MEIER METHOD; MICROBIOLOGY; MIDDLE AGED; PRESCHOOL CHILD; RISK FACTOR; ANTIMICROBIAL THERAPY; CATHETER INFECTION; CAUSE OF DEATH; DEVICE INFECTION; DRUG TREATMENT FAILURE; ENTEROBACTER AEROGENES; ISOLATED ORGAN; KLEBSIELLA PNEUMONIAE; LENGTH OF STAY; MULTIDRUG RESISTANCE; MULTIPLE TRAUMA; OUTCOME ASSESSMENT; PRIMARY INFECTION; PROTEUS MIRABILIS; RESPIRATORY FAILURE; RESUSCITATION; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTERIA; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; FEMALE; HUMANS; INFANT; INTENSIVE CARE UNITS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; RISK FACTORS; TREATMENT OUTCOME; TUNISIA; YOUNG ADULT;

EID: 77955350774     PISSN: 15076164     EISSN: 16433742     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Vincent JL, Bihari DJ, Suter PM et al: The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA, 1995; 274: 639-44
2. Richards MJ, Edwards JR, Culver DH, Gaynes RP: Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med, 1999; 27: 887-92
3. Alberti C, Brun-Buisson C, Burchardi H et al: Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med, 2002; 28: 108-21
4. Cevik MA, Yilmaz GR, Erdinc FS et al: Relationship between nosocomial infection and mortality in a neurology intensive care unit in Turkey. J Hosp Infect, 2005; 59: 324-30
5. Vosylius S, Sipylaite J, Ivaskevicius J: Intensive care unit acquired infection: a prevalence and impact on morbidity and mortality. Acta Anaesthesiol Scand, 2003; 47: 1132-37
6. Legras A, Malvy D, Quinioux AI et al: Nosocomial infections: prospective survey of incidence in five French intensive care units. Intensive Care Med, 1998; 24: 1040-46
7. Luzzati R, Antozzi L, Bellocco R et al: Prevalence of nosocomial infections in Intensive Care Units in Triveneto area, Italy. Minerva Anestesiol, 2001; 67: 647-52
8. Toufen Junior C, Hovnanian AL, Franca SA, Carvalho CR: Prevalence rates of infection in intensive care units of a tertiary teaching hospital. Rev Hosp Clin Fac Med Sao Paulo, 2003; 58: 254-59
9. Esen S, Leblebicioglu H: Prevalence of nosocomial infections at intensive care units in Turkey: a multicentre 1-day point prevalence study. Scand J Infect Dis, 2004; 36: 144-48
10. Reed CS, Gorrie G, Spelman D: Hospital infection control in Australia. J Hosp Infect, 2003; 54: 267-71
11. Yologlu S, Durmaz B, Bayindir Y: Nosocomial infections and risk factors in intensive care units. New Microbiol, 2003; 26: 299-303
12. Hu KK, Veenstra DL, Lipsky BA, Saint S: Use of maximal sterile barriers during central venous catheter insertion: clinical and economic outcomes. Clin Infect Dis, 2004; 39: 1441-45
13. Teasdale G, Jennett B: Assessment of coma and impaired consciousness. A practical scale. Lancet, 1974; 13,2 (7872): 81-84
14. Le Gall JR, Lemeshow S, Saulnier F: A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA, 1993; 270: 2957-63
15. Garner JS, Jarvis WR, Emori TG et al: CDC definitions for nosocomial infections. Am J Infect Control, 1988; 16: 128-40
16. Marquette CH, Georges H, Wallet F et al: Diagnostic efficiency of endotracheal aspirates with quantitative bacterial cultures in intubated patients with suspected pneumonia. Comparison with the protected specimen brush. Am Rev Respir Dis, 1993; 148: 138-44
17. Bone RC: Sepsis, the sepsis syndrome, multi-organ failure: a plea for comparable definitions. Ann Intern Med, 1995; 114: 332-33
18. Kollef MH, Schuster DP: The acute respiratory distress syndrome. N Engl J Med, 1995; 332: 27-37
19. Fagon JY, Chastre J, Hance AJ et al: Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med, 1993; 94: 281-88
20. Girou E, Stephan F, Novara A et al: Risk factors and outcome of nosocomial infections: results of a matched case-control study of ICU patients. Am J Respir Crit Care Med, 1998; 157: 1151-58
21. Kang CI, Kim SH, Park WB et al: Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother, 2005; 49: 760-66
22. Tumbarello M, Sanguinetti M, Montuori E et al: Predictors of Mortality in Patients with Bloodstream Infections Caused by Extended-Spectrumb-Lactamase-Producing Enterobacteriaceae: Importance of Inadequate Initial Antimicrobial Treatment. Antimicrob Agents Chemother, 2007; 51: 1987-94
23. Kreger BE, Craven DE, McCabe WR: Gram-negative bacteremia. IV. Reevaluation of clinical features and treatment in 612 patients. Am J Med, 1980; 68: 344-55
24. Luna CM, Vujacich P, Niederman MS et al: Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest, 1997; 111: 676-85
25. Rello J, Gallego M, Mariscal D et al: The value of routine microbial investigation in ventilator-associated pneumonia. Am J Respir Crit Care Med, 1997; 156: 196-200
26. Kollef MH, Bock KR, Richards RD, Hearns ML: The safety and diagnostic accuracy of minibronchoalveolar lavage in patients with suspected ventilator-associated pneumonia. Ann Intern Med, 1995; 122: 743-48
27. Iregui M, Ward S, Sherman G et al: Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest, 2002; 122: 262-68